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Participation  of thymus humoral factors  (THF) 1 in  the  conferment  of  im- 
mune reactivity has been unequivocally demonstrated  in  the  past few years. 
The original assumptions of a humoral factor activity stemmed from studies of 
partial recovery of cell-mediated and humoral-immune reactions in thymecto- 
mized mice implanted with thymus tissue in cell impermeable chambers (1-4). 
Indeed, it was subsequently demonstrated that administration of extracts from 
thymus tissue of different animal origin to neonatally thymectomized mice pre- 
vented wasting disease (5), and partially restored the ability to produce a pri- 
mary immune response to sheep red blood cells  (SRBC)  (6,  7),  as well as  to 
reject  skin  and  tumor  allogeneic  grafts  (8).  Furthermore,  spleen  cells  from 
neonatally thymectomized mice gained the capacity to elicit in vitro a graft-vs.- 
host  (GvH) response, when incubated in dialyzed THF preparations  (9). At- 
tempts to characterize the  target cell for the  activity of THF in this  system 
showed that bone marrow ceils treated with THF and transferred through an 
intermediate recipient acquired immunological competence, as measured in the 
same GvH in vitro system (10). These observations conform with the conclu- 
sions derived from in vitro studies on interactions of thymus with bone marrow 
and spleen tissue  (11).  However, the exact identity of the target cell for THF 
activity within the bone marrow cell population is still obscure, since the bone 
marrow  of normal  animals contains  precursors  of B  lymphocytes, as well  as 
some T  lymphocytes (12,  13).  The question therefore arises, which cell type is 
affected by THF. Does THF contribute to the maturation of B  or T, or both 
lymphoid cell types? Furthermore, in view of the concept that lymphocytes of 
the thymus in the adult develop from cells of bone marrow origin (14), we at- 
tempted  to  test  whether  differentiation  to  active T  cells within  the  thymus 
depends  entirely on  the  effect of THF.  Our  preliminary observations in  this 
study have been reported (15). 
* Supported by a grant from the Talisman Foundation, New York, and by The National 
Institutes  of Health agreement NCI-G-72-3890. 
1  Abbreviations used in ttds paper: BM, bone marrow; GvH, graft-vs.-host; PFC, plaque- 
forming  ceils; SRBC, sheep red blood  cells; THF, thymus humoral factor. 
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Materials and Methods 
Mice.--(BALB/c  X  C57BL/6)Ft,  at  the age  of 8-10 wk,  were  used throughout these 
experiments. Thymectomy was performed under Nembutal anesthesia and the thymus was 
removed by suction. At the end of the experiment any animal found to contain a  thymic 
remnant was discarded. 
X Irradiation.-- Mice were exposed to total body irradiation 7 days after thymectomy. The 
animals were given a single dose of 750 R  from a 6°Co source (gamma beam  150 A,  Atomic 
Energy of Canada Ltd., Ottawa, Ontario, Canada) 60 R/rain, focal skin distance, 34 inches. 
Preparation of Cells.--Thymus  and  bone  marrow  cell  suspensions were  prepared  from 
s)mgeneic  (BALB/c  X  C57BL/6)Fl donor mice as previously described  (16),  and were in- 
jected intravenously. In most of the experiments thymus cells were administered immediately 
after irradiation, whereas the bone marrow cells were given 7 days later. 
Immunization and Assay.--O.1 ml of a  10% suspension of SRBC was injected intraperi- 
toneally twice,  24 h  and 7 days after irradiation. The number of hemolytic plaque-forming 
cells (PFC) was determined by Jerne's technique (17),  5  6 days after the second injection of 
antigen. The schedule used in these experiments is described in Fig. 1. 
Treatment wilh Thymus Ilumoral Factor (THF).--Extracts from calf thymus were prepared 
and dialyzed as previously described (18). In addition, certain fractions obtained by methanol 
chloroform extraction were also used. The preparations employed contained 1 mg protein per 
milliliter dialyzed THF.  Every sample of THF was tested for reactivation of the ability of 
spleen cells from neonatally thymectomized mice to elicit an in vitro GvH response (9). In vivo 
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treatment:  mice were injected intraperitoneally with 0.5-1.0 ml of TttF. In vitro treatment: 
cells were incubated for 1 h at 37°C ~ith 2~,~ THF, in Eagle's medium supplemented with 
agamma globulin horse serum, washed and resuspended in Eagle's medium free of TttF. 
Statistical Evaluation.---The results obtained were submitted to Student's t test for evalua- 
tion of significance. 
RESULTS 
Previous experiments performed in this laboratory have shown that treatment 
with THF of spleen cells front neonatally thymectomized mice restored their 
competence to induce a cell-mediated immune response as measured in a GvH 
reaction in vitro (9). It has been suggested that THF acts on precursors of T 
cells, since the T  cells were reported to participate in the GvH response (19). 
However, during the activation process by THF, no increase in the number of 
0-bearing cells was observed in the treated cell population (20). Two alternative 
hypotheses could explain these results:  (e) THF permits bone marrow cells to 
differentiate to reactive T  cells which do not possess the 0-antigen, or (b) THF 
induces functional maturation of cells which  already carry the 0-antigen.  Ac- 
cording to the first hypothesis we assumed that if bone marrow cells can develop 
into  T  cells  after treatment with THF,  such  treated  cells should  be  able  to 
interact with  B  cells in response to antigenic  stimulation,  in a  system which 
requires cooperation of T  and B cells (21, 22). To test this possibility, thymecto- 
mized mice were lethally irradiated, and injected with 30 X  i06  bone marrow 
cells, 0.5 ml THF, and 0.1 ml 10% SRBC. Additional treatment with the same 
amount of bone marrow cells and SRBC  without THF was repeated a  week 
later (group I, Fig. 2). Controls included one group treated as above but without 
THF  (group II), a  group which was not injected with  SRBC  (group III), a 
group which received two injections of bone marrow cells only (group IV), and 
a  last one  that served as positive controls,  in which  thymic cells were  given 
instead  of the first injection  of bone marrow cells. Experimental  and  control 
animals were sacrificed 5 days after the second injection of antigen,  and their 
spleens were assayed for the number of PFC.  As shown in Fig.  2,  spleens of 
mice injected with bone marrow and THF (group I) did not manifest any in- 
crease in the number of PFC,  as compared to animals that were not injected 
with THF (group II). A significant response was obtained only in animals in- 
jected first with thymic cells instead of bone marrow cells  (group V). It was, 
therefore,  concluded  that under  the  experimental conditions  employed, bone 
marrow cells subjected to THF treatment in the absence of intact thymus tissue 
do not function as T  cells. 
These results could be attributed to the possibility that the number of target 
cells for THF effect in the bone marrow is too low to be detectable by T  helper 
function  in  this  system. The  same experiment was therefore performed with 
higher  numbers of bone marrow cells given at the first injection.  Thymecto- 
mized, irradiated  mice were thus inoculated with  l0 s bone marrow cells,  and 
injections of THF and SRBC followed as in the previous experiment (group I, ROTTER~ GLOBERSON~ NAKAMURA~ AND  TRAININ  133 
Table I). A  control group was injected with the same number of bone marrow 
cells  without  THF  (group  II),  and  another  control  group  received  5  X  106 
thymus  cells  and  SRBC  (group  III).  All  animals  were  given 30  X  106  bone 
marrow  cells and  SRBC  1  wk later.  The results obtained  clearly indicate  that 
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FIG. 2. Antibody response to SRBC measured in the spleen of thymectomized irradiated 
mice injected with BM cells and THF. O  =  number of PFC in individual spleens.  A  =  mean. 
TABLE I 
Number of PFC in the Spleen of Thymeclomized Irradiated ~[ice Injected with High 1Vumbers 
of Bone Marrow Cells and THF 
Group  Treatment*  No. of PFC/spleen  No. ot  animals 
I  108 BM, 0.5 ml THF  380  (20-1,040)  9 
II  l0 s BM  295  (80-1,000)  10 
III  5 X  106 thymus  4,565  (1,900-6,000)  3 
* All animals were injected with SRBC and  1 wk later inoculated with 30 X  106 bone 
marrow ceils and SRBC again. 134  TARGET  CELL  t'OR  TtI1  ~  ACTIVITY 
even when higher numbers of bone marrow cells were used, no effect of THF on 
these cells could be observed. 
Consequently, in the next series of experiments we decided to test the alter- 
native hypothesis, namely, that THF induces differentiation of thymocytes to 
T  cells. The system employed was similar  to that used in the previous experi- 
ments.  Thymectomized, irradiated  mice were inoculated with  10  s thymus cells 
and in  addition,  received 0.5  ml THF  and 0.1  ml  10g  7,  SRBC. The mice were 
subsequently  injected with 30  X  10  ~ bone marrow cells and once more stimu- 
lated with SRBC  (group I, Fig. 3).  Controls included one group as above, but 
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FIG. 3. Antibody  response to SRBC measured in the spleen of thymectomized  irradiated 
mice injected with thymus cells and THF. ©  =  number of PFC in individual spleens. A  = 
mean, 
without THF (group II), another control group consisted of animals which were 
first  given  10  s  thymus cells  only, whereas  THF  was  given  together  with  the 
bone marrow cells in the second injection  (group III), and a  last control group 
(IV) in which the animals received thymus cells and bone marrow cells without 
any injection of SRBC. 
As shown in  Fig.  3,  simultaneous  administration  of THF  and thymus cells 
(group I)  increased  significantly the  number of PFC,  as compared to control 
group If,  suggesting that  THF  increases  the  helper  effect of the  thymus cell 
population.  This  effect  of THF  on  cell  maturation  appears  to be  specific for 
thymic cells,  since THF  given simultaneously with  bone marrow cells  (group 
III) did not increase  the number of PFC. Therefore, the possibility that THF ROTTER,  GLOBERSON~ NAKAMURA,  AND  TRAININ  135 
affected bone marrow cells and thus increased the population of mature B cells 
does not seem plausible under the present experimental conditions. 
When these experiments were repeated with a  constant low dose of thymo- 
cytes followed by inoculation with bone marrow cells incubated with THF, no 
increase in  the number of PFC was observed (Table II). Thus,  we could not 
detect any effect of THF on bone marrow cells. 
In order to find out whether THF acts directly on the target  thymus cells 
through direct  contact,  or whether  the  effect is  indirect,  we  tested  whether 
exposure of the thymus cells to THF in vitro would also result in an enhanced 
immunological activity. Thymus cells at a concentration of 30 X  10  a cells per 
milliliter  were  incubated  in  Eagle's medium supplemented  with  horse serum 
and with THF for 1 h  at 37°C  with continuous shaking.  The cells  were  then 
washed  and  inoculated  at  a  dose  of 108 cells  into  thymectomized, irradiated 
recipients  challenged  with  SRBC.  Subsequently,  the  animals  received  bone 
TABLE II 
2Vunzber of PFC in the Spleen  of Thymectomized  Irradiated  Mice Injected with Thymus  Cells 
and  Snbsequenlly  with  Bone  Marrow  Cells Incubated  with  THF 
Group  Treatment of BM cells*  No. of PFC/spleen  No, o[  animals 
I  Incubation in THF  964  (280  2,010)  7 
II  Incubation in spleen extract  1,185  (450-2,100)  7 
III  Incubation in medium  685  (650-720)  4 
IV  Cells kept at 4°C  1,143  (870-2,250)  5 
* All animals received  5  X  106 thymus cells and  antigen a  week  before inoculation of 
treated 30  X  106 bone marrow cells. 
marrow cells  and  an  additional  injection of  SRBC.  (Fig.  4,  group I).  In one 
control group, thymus cells were incubated under similar conditions, but in the 
absence of THF  (II). In another control group  thymus cells  were incubated 
with  THF at 4°C  (III), whereas in  group IV thymus cells  were kept at 4°C 
without THF. In the last group (V) untreated  thymocytes were injected with 
bone marrow cells without SRBC. The results obtained indicate that incubation 
of thymus cells with THF at 37°C caused a significant increase in the number 
of PFC, as compared to thymus cells incubated under the same conditions but 
without THF. This effect seems to be temperature-dependent, since incubation 
with THF in the cold did not exert a similar effect. The possibility that thymic 
cells  were  damaged when kept in  the  cold,  and  were  therefore inactive,  was 
ruled out, since group III manifested the same activity as did the control group 
of thymus cells incubated at 4°C without THF (group IV). 
From the data accumulated in the above experiments it appears that there is 
a significant increase in the number of PFC when thymus cells are treated with 
THF either in vivo or in vitro. However, in the system used we measured the 136  TARGET  CELL  FOR  TtI~  ACTIVITY 
number of antibody-producing cells, which represents  the activity of the bone 
marrow-derived  cell  population.  Consequently,  it  was  important  to  evaluate 
quantitatively the increment ill helper T  cell activity. 
In  order  to  clarify the  relationship  between  an increase  in  the  number  of 
active T  cells and  the resulting number of PFC,  an experiment was designed 
using progressive doses of thymus cells (106, 5  X  10  ~, l07, 5  X  107, and  10s). 
The cells were inoculated into thymectomized irradiated mice, challenged with 
SRBC, and  subsequently injected  with  a  constant number of 30  ×  l06  bone 
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FIG. 4. Antibody response to SRBC measured in the spleen of thymectomized irradiated 
mice injected with thymus cells previously incubated  with THF in vitro.  ©  =  number  of 
PFC in individual spleens. A  =  mean. 
marrow cells.  The results of this experiment are summarized in Fig. 5. As can 
be seen in the figure, a  10-fold increase in the number of thymus cells injected 
resulted in an 80% increase in the number of PFC,  and at the higher doses of 
cells the curve reached a plateau. 
In view of these results,  we decided to investigate the effect of THF on low 
concentrations of thymus cells. Thymectomized irradiated mice were inoculated 
with 5 X  106 thymus cells and simultaneously injected with 0.5 ml of THF. On 
the next day the animals were challenged with SRBC and subsequently injected 
with 30 X  10  ~ bone marrow cells (group I). Control groups included one group 
similar  to the  experimental  one, but without THF  treatment  (group II), and ROTTER~  GLOBERSON,  NAKAMURA~  AND  TRAININ  137 
another consisting of animals injected with thymus and bone marrow cells only 
(group III). As seen in Fig. 6, animals receiving THF together with the thymic 
cells  showed  a  striking  increase  in  the number of PFC,  as  compared  to  that 
observed  in  the  control  groups.  In  the  next  experiment  thymus  cells  were 
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FIG. 5. Antibody response to SRBC measured in the spleen of thymectomized irradiated 
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O  =  number of :PFC in individual spleens. •  =  mean. 
incubated at a concentration of 30 X  l0  G  cells/milliliter at 37°C in the presence 
of THF.  The  cells  were  washed  and  injected  in  doses  of  15  X  106  cells  per 
animal  group (I, Table III). In one control group cells were incubated  in the 
presence  of an  inactive  fraction  of THF,  at  the  same  protein  concentration 
(group  II).  Another  control  group  consisted  of  thymus  cells  incubated  in 138  TARGET  CELL  I~OR  TII]~  ACTIVITY 
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TABLE  III 
Number  of PFC in the Spleen  of Thymectomized  Irradiated  Mice Injected  with Low Doses of 
Thymus Cells Incubated  in  THF 
Group  ! 
I 
II 
Ill 
IV 
Exp.  1  [  Exp.  2 
i 
Incubation  of thymus  cells*  i  i  No.  of PFC/spleen  No.  of PFC/spleen  I  reals 
i 
THF active fraction  I 7,590  (6,780-12,060) 
THF inactive fraction  I 1,875  (495-3,390) 
Medium  2,958  (2,400-4,260) 
Ceils kept in the cold  2,384  (1,530-3,510) 
6  3,301  (350-9,500) 
6  610  (150-1,850) 
5  i  1,483  (250-2,500) 
6  i  762  (300-1,500) 
* All animals received 15  X  106 treated thymus cells and were challenged with SRBC, 
and 1 wk later the animals were injected with 30 X  106 bone marrow cells and SRBC again 
(P << O.Ol). 
medium only (group III).  In the last control, the  thymus cell suspension was 
kept  at  4°C  (group  IV).  All animals were  challenged with  SRBC  on the day 
after  thymus cell inoculation, and  I  wk  later  the  animals were  injected with 
30  X  106 bone marrow  and again with antigen. The results of the two experi- ROTTER,  GLOBERSON,  NAKAMURA,  AND  TRAININ  139 
ments presented above indicate that incubation of thymus cells in the presence 
of the active fraction of THF caused a striking increase in the number of PFC. 
Thus, a significant increase in the number of PFC, which was manifested after 
in vivo as well as in vitro treatment of low numbers of thymic ceils with THF, 
demonstrates unequivocally that THF enhances  the  activity of T  cells even 
when the cells were applied in limited numbers. 
DISCUSSION 
The results accumulated  in the present experiments clearly indicate that THF 
activates thymus cells to acquire a higher T  helper cell activity, as measured 
by the response to SRBC, since such treatment caused a significant increase in 
the number of PFC in the experimental system used. On the other hand, bone 
marrow cells did not manifest any T  cell activity after THF treatment under 
similar conditions.  Nor did THF affect B  cell activity as shown from the re- 
sponse of animals reconstituted  with  normal  thymus cells,  and  THF-treated 
bone marrow cells which was not higher than that of control animals receiving 
the untreated bone marrow. 
While  in  these  experiments  no  effect  of THF  on  bone  marrow  cells  was 
demonstrated,  it has been previously demonstrated  that T  cell function  was 
acquired by bone marrow cells after THF treatment when tested in the in vitro 
GvH assay (9). Whether these results indicate two different target cell popula- 
tions for the activity of THF is open to discussion.  It is possible that in the 
GvH response  the  target  cell  is not  a  precursor  of a  T  cell,  whereas in  the 
humoral response, THF contributes to further maturation of thymus cell popu- 
lations only.  Since the  bone marrow cell population used in  the  GvH experi- 
ments of Small and Trainin  (10)  were not previously treated with anti-0 anti- 
serum, it is possible that THF activated a minor population of T  cells which is 
known to exist in the bone marrow of mice (12,  13, 23), and these may actually 
be the active cells in eliciting the GvH response.  Furthermore,  Burleson  and 
Levey (24)  reported that when bone marrow cells of mice were fractionated on 
bovine serum albumin gradient, an active cell population was obtained, capable 
of inducing a  GvH response in vivo in newborn mice. Similarly, ¥oshida and 
Osmond  (25),  working  with  Lewis  rats  (Lewis  Corp.,  Woodbury,  Conn.), 
demonstrated that lymphocyte-rich fractions separated from the bone marrow 
by sucrose gradient, manifested a high GvH activity, as measured by popliteal 
lymph node enlargement. These experiments indicate that a certain cell popu- 
lation within  the  bone marrow is able to cause a  GvH response,  but  the de- 
tection of this capacity is possible only after its concentration by a variety of 
methods. 
With regard to the antibody response to SRBC, it is generally accepted that 
antibodies are produced in thymectomized irradiated mice if bone marrow cells 
are administered together with thymus cells (1-4). However, Playfair obtained 
some degree of humoral response to SRBC  (26)  when bone marrow cells only 140  TARGET  CELL  FOR  TI-IF ACTIVITY 
were injected at very high doses. It is possible that the T  ceils for cell-mediated 
reactivity, and the T helper cells for humoral response, represent different types 
of cell populations, as suggested by Sega[ et al. (27). Another possibility is that 
both in the cellular and the humoraI responses the  same type of T  cell is in- 
volved, yet much higher doses of bone marrow cells are required for a detectable 
T  cell response in antibody production.  Accordingly, while bone marrow cells 
acquire a high level of T  cell function after THF treatment, as expressed in the 
GvH response (9), this may still be insufficient to perform a T  helper function 
for the humoral response. The fact that THF can induce T cell activity without 
any  effect on  other  manifestations  of  this  population  was  demonstrated  by 
Lonai et al.  (20). Treatment of different lymphoid cell populations with THF 
did not cause any increase in the number of 0-positive cells,  although they ac- 
quired the capacity to elicit a  GvH response. This suggests that, in the GvH 
reaction system, THF endows a sector of the bone marrow cell population with 
T  cell properties, without acquiring a T  cell marker such as the 0-antigen, and 
with no  effect on  the function  in  the  humoral  response. Acquisition  of these 
activities by the bone marrow population may require  an additional phase of 
differentiation. 
Finally, the fact that incubation of thymus cells with THF at 37°C for 1 h 
only was sufficient to increase their T helper function, demonstrates that in this 
system, as well as in the GvH response (I0), THF triggers a critical step, in- 
volving some metabolic process, since  treatment at 4°C  did not lead  to  any 
enhancement of the response. 
SUMMARY 
The immune response to SRBC was measured in the spleens of adult thymec- 
tomized,  total  body  irradiated  mice  injected  with  various  combinations  of 
thymus and bone marrow cells together with thymic humoral factor  (THF). 
It was found that the number of plaque-forming cells was significantly increased 
when TItF was given in vivo immediately after thymus cell administration or 
when thymus cells were incubated in THF before injection. On the other hand, 
bone marrow cells equally treated did not manifest any T  cell activity, since 
THF-treated bone marrow cells were not able to substitute thymus ceils in the 
system used.  The  results  accumulated  in  the  present  experiments  indicate, 
therefore, that the target ceils for THF activity are thymus cells which acquire 
a higher T  helper cell capacity after THF treatment. 
The authors wish to express their thanks to Havazelet Cohen and Itzhak Serussi for ex- 
cellent technical assistance. 
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